Sponsored by the ASIP Education Committee
Session Description: Unresolved inflammation is a major mechanism of pathogenesis in many human diseases. A paradigm shift is emerging in our understanding of the pathogenesis of inflammation which results not only from persistent activation of inflammatory signals, but also from the active loss of pro-resolution mechanisms. Differentiating between the suppression and resolution of inflammation driven by pro-resolution mediators is critical for the treatment of various inflammatory diseases.
Chair
Dipak Panigrahy, MD
Beth Israel Deaconess Medical Center Harvard Medical School
Pro-oncogenic Potential of Apoptotic Cells in the Tumor Microenvironment
Christopher D. Gregory, PhD
University of Edinburgh Centre for Inflammation Research
Queen’s Medical Research Institute Edinburgh, UK
Microbes, Tumor-elicited Inflammation and Cancer
Sergei Grivennikov, PhD
Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center, Los Angeles, CA
Inflammation in Health and Disease
Ann C. Skulas-Ray, PhD
Department of Nutritional Sciences
School of Nutritional Sciences and Wellness
The University of Arizona
College of Agriculture and Life Sciences Tuscon, AZ
Inflammation and Cell Death in Tuberculosis
Selvakumar Subbian, PhD
Public Health Research Institute
New Jersey Medical School
Rutgers University Newark, NJ
Register soon for the best rates.
Not a Member? Save on registration when you join the ASIP!
NOW is the time to join so you can receive discounted registration rates
AND the many benefits that come with membership.
Learn more
Abstract Deadline: November 30
Apply for Travel Awards TODAY!
You must be logged in to post a comment.